Menu
Recruiting NCT06745895

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

No phase Interventional Colorectal Cancer Screening Hepatitis C Virus

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: MATCHES.
Who it may be relevant to
Registry conditions: Colorectal Cancer Screening, Hepatitis C Virus. Basic parameters: 45 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES)

Overview

This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.

Detailed description

While this is a multi-level intervention study, only information related to the patient-level intervention is being reported for the purposes ClinicalTrials.gov.

Interventions

  • Behavioral MATCHES
    Participants will be asked to complete a survey with specific topics including Hepatitis C (HCV) and Colorectal (CRC) knowledge and health beliefs, screening intentions and demographic characteristics. Participants will be provided with education intervention materials (for example, a booklet) either in-person or via mail, access to free stool-based CRC screening, and access to free HCV screening. Approximately 1-2 weeks after receiving the education materials, participants will be asked to co

Primary outcome measures

  • Screening Uptake for Hepatitis C Virus (HCV) and Colorectal Cancer (CRC) [Time frame: Up to 12 Months]
Secondary outcome measures (5)
  • Screening Completion for Hepatitis C Virus (HCV) [Time frame: Up to 41 Months]
  • Screening Completion for Colorectal Cancer (CRC) [Time frame: Up to 41 Months]
  • Screening Test Results for Hepatitis C (HCV) [Time frame: Up to 41 Months]
  • Screening Test Results for Colorectal Cancer (CRC) [Time frame: Up to 41 Months]
  • Completion of repeat CRC Screening [Time frame: Up to 41 Months]

Eligibility criteria

Inclusion criteria

  • Participants must be receiving care at one of the participating FQHC clinics.
  • Participants must be 45-75 years of age.
  • Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months.
  • Participants must never have had Hepatitis C Virus (HCV) antibody screening.
  • Participants must be able to read, write, and understand English or Spanish.
  • Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating.
  • Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC).
  • Participants must be asymptomatic for HCV.
  • Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention.
  • Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM.
  • Participants completing qualitative interviews must be willing to be audio recorded.
  • Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months.
  • All Participants must be able to provide informed consent.

Exclusion criteria

  • Participants that do not meet all Inclusion Eligibility requirements will be excluded.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Screening

Study locations

United States · 1 center
  • Moffitt Cancer Center — Tampa

Publications

  • Abdulla R, Boxtha C, Courtney EP, Anyanwu OA, Sutton SK, Chung-Bridges K, Kassaye HG, Philippe E, Mudon KA, Frias E, Parras D, Avrilien N, Friedman M, Turner K, Coronado GD, Champion VL, Tobin JN, Vadaparampil ST, Gwede CK, Christy SM. Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES): Study protocol for a hybrid 1 stepped-wedge multibehavioral randomized PMID 41692274

Identifiers

NCT: NCT06745895 · MCC-23232

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗